Google AI

Bora Pharmaceuticals 2Q25 Operating Margin Expanded 5 Percentage Points, Reaching Quarterly High Since The Start of Integration in 4Q24; Strong Momentum Poised to Accelerate in 2H25 As Operational Efficiency Gains Materialize

HONG KONG SAR - Media OutReach Newswire - 8 August 2025 - Bora Pharmaceuticals (TWSE: 6472) today announced its financial results and operational highlights for second quarter of 2025.

Quarterly Business and Financial Highlights

· Company reported quarterly basic EPS of NT$5.95, with NT$1.81 from discontinued operations.
hacklink makrobetzlibraryzlibraryzlibraryVdcasinovippark girisanonymous online casino1xbetVdcasino resmihttps://bahisfair-gunceladres.world/tr/jojobetcasino zonder cruksRaja 567verovapaat kasinotcasino en ligne populairepadisahbet giriscasibomcasibomhttps://viljo-kasinot.ioPadişahbethitbet girisVipparkjojobetvippark girisjojobetcasinolevantcasinolevantcasinolevantcasinolevantcasinolevantcasinolevantcasinolevantcasinolevantmarsbahismarsbahisjojobethacklink panelslot sitelerijojobetnon gamstopgamstop.orgBetim